Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / LPAR3

LPAR3

Basics

Aliases:
This biomarker is also known as:
  • endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7,
  • LP-A3,
  • HOFNH30,
  • LPA-3,
  • GPCR,
  • Edg-7,
  • lysophosphatidic acid receptor 3,
  • LPA receptor 3,
  • FLJ98231,
  • EDG7,
  • LPA3,
  • RP4-678I3,

View in BioMuta

Description…

LPAR3, a multi-pass cell membrane protein, is a receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. LPAR3 seems to be coupled to the G(i)/G(o) and G(q) families of heteromeric G proteins. LPAR3 may play a role in the development of ovarian cancer. This protein is most abundantly expressed in prostate, testes, pancreas, and heart, with moderate levels in lung and ovary. There is no detectable expression in brain, placenta, liver, skeletal muscle, kidney, spleen, thymus, small intestine, colon, or peripheral blood leukocytes.

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: LPAR3

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place January 20–21, 2016 in Bethesda, Maryland.

Announcement 08/26/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held Wednesday-Thursday, January 20-21, 2016, on the NCI campus. More information will be available later this summer.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to http://grants.nih.gov /grants/guide/ pa-files/ PAR-15-289.html.